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Abstract: Background: This study compared the efficacy of two multi-component m-health
interventions with a wait-list control group on body weight (primary outcome), and secondary
outcomes of cardiovascular risk factors, lifestyle behaviours, and mental health. Methods: Three-arm
randomised controlled trial (Enhanced: physical activity, diet, sleep, Traditional: physical activity,
diet, Control) with assessments conducted at baseline, 6 and 12 months. Participants (n = 116)
were overweight or obese adults aged 19–65 (M = 44.5 [SD = 10.5]). The 6-month intervention was
delivered via a smartphone app providing educational materials, goal-setting, self-monitoring and
feedback, and also included one face-to-face dietary consultation, a Fitbit and scales. The trial was
prospectively registered and conducted between May 2017 and September 2018. Group differences
on primary and secondary outcomes were examined between the Pooled Intervention groups
(Pooled Intervention = Enhanced and Traditional) and Control groups, and then between Enhanced
and Traditional groups. Results: Nineteen participants (16.4%) formally withdrew from the trial.
Compared with the Control group, average body weight of the Pooled Intervention group did
not differ at 6 (between-group difference = −0.92, (95% CI −3.33, 1.48)) or 12 months (0.00, (95%
CI −2.62, 2.62)). Compared with the Control group, the Pooled Intervention group significantly
increased resistance training (OR = 7.83, (95% CI 1.08, 56.63)) and reduced energy intake at 6 months
(−1037.03, (−2028.84, −45.22)), and improved insomnia symptoms at 12 months (−2.59, (−4.79, −0.39)).
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Compared with the Traditional group, the Enhanced group had increased waist circumferences (2.69,
(0.20, 5.18)) and sedentary time at 6 months (105.66, (30.83, 180.48)), and improved bed time variability
at 12 months (−1.08, (−1.86, −0.29)). No other significant differences were observed between groups.
Conclusions: Relative to Controls, the Pooled Intervention groups did not differ on body weight
but improved resistance training, and reduced energy intake and insomnia symptom severity. No
additional weight loss was apparent when targeting improvements in physical activity, diet and sleep
in combination compared with physical activity and diet.
Keywords: adult; diet; m-health; physical activity; sleep; weight loss
1. Introduction
Globally, overweight and obesity are significant contributors to morbidity and mortality [1].
Traditionally, behavioural weight loss interventions aim to increase physical activity, improve diet
quality and reduce total energy intake to promote weight loss [2]. Although traditional weight loss
interventions achieve modest short-term weight loss (e.g., <3.80 kg over 6 months) relative to control
groups [3,4], improving sleep in combination with physical activity and diet has the potential to
contribute to greater weight loss than interventions only targeting physical activity and diet [5–7]. This
is relevant as between 20 and 30% of adults engage in a pattern of behaviours characterised by low
levels of physical activity, poor dietary behaviours and insufficient sleep [8].
Optimal sleep health is characterised by duration, quality and timing of sleep that leaves a
person satisfied with their sleep and alert during the day [9]. Potential mechanisms linking sleep with
weight regulation include reduced activity levels among people with short duration or poor quality
sleep [10,11]. Shorter sleep duration (<5.5 hrs/night) is also associated with increased energy intake,
greater likelihood to select energy-dense foods, and poorer regulation of hunger [12–14]. Additionally,
having poorer quality, shorter sleep duration (<7 hrs/night), or sleep-disordered breathing at the start of
a traditional weight loss intervention is associated with lower weight loss in intervention studies [15,16].
However, these studies did not specifically aim to improve sleep as part of the intervention [15,16].
To our knowledge, only one study has examined how improving sleep, in combination with physical
activity and diet, influenced weight loss in adults [5]. This study reported greater weight loss from
a physical activity, diet and sleep health intervention (5%) compared to an intervention without a
sleep component (2%) [5]. The sleep component of the combined intervention commenced in week 4
of the 12-week intervention, potentially limiting the improvements in sleep and reducing potential
impacts on weight loss [5]. Despite these promising results, further research is necessary to examine
how improving sleep influences weight loss over longer periods of time.
Due to the high prevalence of overweight and obesity, it is important that intervention approaches
have the potential for wide reach and access [3,17]. Interventions which include electronic components
such as e-health (i.e., website) and m-health (i.e., apps) offer opportunities for delivering behavioural
and weight loss interventions in a format that is scalable, and allow participation at times that are
convenient to individuals [18,19]. Few (n = 4) m-health interventions target physical activity, diet and
sleep behaviours in combination, and none have focussed on weight loss [20]. The primary aim of
the current study was to compare the efficacy of two multi-component m-health interventions pooled
together with a wait-list Control group on body weight (primary outcome) and secondary outcomes
including cardiovascular risk factors (i.e., waist circumference, HbA1c), behaviours (i.e., physical
activity, diet, sleep) and mental health (i.e., depression, anxiety and stress symptoms). The secondary
aim was to compare the relative efficacy of a physical activity, dietary behaviour and sleep intervention
(Enhanced intervention), with a physical activity and dietary behaviour only intervention (Traditional
intervention) on both primary and secondary outcomes. The hypotheses were that the both the
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Enhanced and the Traditional interventions would achieve greater weight loss than the Control group,
and that the Enhanced intervention would achieve greater weight loss than the Traditional intervention.
2. Methods
2.1. Trial Design
The Move, Eat and Sleep study was a three-arm randomised controlled trial (RCT) with in-person
assessments conducted at baseline, 6 months (primary end point) and 12 months (Figure 1). The detailed
study protocol has been published earlier [6]. In summary, adults (n = 116; Female = 82) living in
the Newcastle area, New South Wales, Australia were recruited (May–September 2017), primarily by
newspaper and radio stories, participant registries, and electronic communication (email lists, social
media advertising). Inclusion criteria were age 18–65 years, a BMI between 25.0 and 40.0 kg/m2, and
possession of an iOS/Android smartphone/tablet with internet access. Exclusion criteria were current
use of an activity tracker for physical activity and/or sleep, current pregnancy, reported presence of a
doctor-diagnosed sleep disorder, current use of medication to assist with sleep or weight management,
presence of a condition which precluded activity, diet and/or sleep behaviour modification, weight
loss ≥4.5 kg in last 3 months, intention to participate in another weight loss trial, previous weight loss
surgery at any time, or current employment involving shift-work on a rotating roster.
All assessments were completed at the University of Newcastle. After completing an online
eligibility survey, individuals were contacted by project staff to complete visit 1 where eligibility
status was confirmed. At visit 1, eligible participants had their HbA1c, height and weight measured,
completed the Australian Eating Survey and were provided with an accelerometer (Geneactiv) to
wear continuously for 8 days. At visit 2 (9 days later), participants returned the accelerometer and
completed an online survey.
After completing baseline assessments at visit 2, participants were randomly allocated (1:1
ratio) to one of the three study groups using secure, web-based randomisation. Allocation was
stratified by baseline BMI (25.0–29.9; 30.0–40.0) using block sizes of 6. Participants who shared their
residence with another participant were allocated to the same group to avoid contamination between
groups. The research assistants who conducted the anthropometric assessments were blinded to group
allocation. The dietitians who provided dietary counselling and participants were not blinded to
group allocation.
Follow-up assessments were conducted at 6 and 12 months (November 2017–September 2018)
post-randomisation. Participants were mailed the accelerometer prior to the 6- and 12-month
assessments and received a gift voucher (AUD 10) at the completion of each assessment. The study
was approved by the Human Research Ethics Committee of the University of Newcastle Australia
(Reference number H-2017-0039) and was prospectively registered (ACTRN12617000735358; Universal
Trial Number U1111-1219-2050). All participants provided informed consent to participate. The funding
bodies had no role in the design, conduct or reporting of the trial.
2.1.1. Intervention
The Enhanced and Traditional group participants were provided with personalised dietary
recommendations, and given access to the ‘Balanced’ smartphone app [6], an additional calorie
counting platform (CalorieKing Wellness Solutions Inc„ La Mesa, CA, USA), a set of body weight
scales (Tanita HD-380), a Fitbit activity tracker (Fitbit Alta) and a participant handbook [6,21,22].
The intervention used behaviour change techniques (e.g., education, goal setting, self-monitoring,
feedback on behaviour) to operationalise constructs from social cognitive and self-regulatory theories
specifical to the target behaviours [23–25]. An overview of the intervention is provided in Supplementary
Table S1. Participants received intervention content specific to their group allocation only.
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Figure 1. Move, Eat and Sleep Study flow chart.
Educational materials detailing how behaviours related to weight loss and target weight loss (5%
weight loss target) were provided via in-app content, email and SMS messages, a printed participant
handbook, and in-person via a dietary counselling session. The handbook provided guidance on
goal setting, action planning, stress management, healthy eating advice and body weight resistance
training activities. The in-person counselling session followed a standardised protocol to provide
personalised dietary advice based on assessment of their current dietary intake, as measured by the
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Australian Eating Survey® (FFQ) and personalised nutrition report (Australian Eating Survey® Version
2, University of Newcastle, Callaghan NSW, Australia) to improve overall diet quality in line with
Australian Dietary Guidelines and the Australian Guide to Healthy Eating [26–29]. Participants were
also provided with a personalised daily energy intake target to create an energy deficit of 2000 kJ
based on the Mifflin-St Jeor equation [30]. Intervention group participants accessed the Balanced app
to set goals and self-monitor weight and target behaviours (daily minutes of moderate-to-vigorous
intensity physical activity, steps, resistance training, and the number of food goals achieved), and
received dynamic feedback on performance relative to their goals [6]. Both intervention groups were
also encouraged to self-monitor and receive feedback on overall diet quality [31] and energy intake
(kilojoules/day) (CalorieKing website or the ControlMyWeight app by CalorieKing) [6].
The Enhanced group also received access to a sleep intervention via the app and participant
handbook [6,21,22] that targeted a reduction in sleep timing variability, promoted sleep hygiene
behaviours and provided stress management and relaxation techniques (e.g., progressive muscle
relaxation, deep breathing exercises, and mindfulness). The Enhanced group could set goals and
self-monitor and receive dynamic feedback on bed times/wake times, sleep quality and sleep hygiene
behaviours [6,21,22]. Participants of both intervention groups received emailed weekly summaries
of their behaviours in relation to their goals based on Balanced app entries, and weekly educational
weight loss facts via SMS. Participants who stopped self-monitoring using the app (≥4/7 days/week)
were sent an SMS to prompt re-engagement [6,21,22].
2.1.2. Measures
Body weight (kg, primary outcome) and height (cm) were measured on calibrated digital scales
(Biospace BSM370 Portable Automatic BMI Stadiometer, Biospace Co, Ltd., Seoul, Korea). Weight
was measured twice in light clothing and without shoes, measures were considered consistent if they
differed by <0.1 kg; if measures varied by more than 0.1 kg a third measurement was taken. Waist
circumference (centimetres) was measured at the narrowest point between the lower costal border and
iliac crest (Seca 203, Seca Gmph & Co., Hamburg, Germany). Waist circumference was measured twice
in light clothing, measures were considered consistent if they differed by <0.5 cm, if measures varied
by more than 0.5 cm a third measurement was taken. Using a capillary blood sample, HbA1c was
measured using capillary blood sample (A1C Now+ (Polymer Technology Systems)).
Participants were asked to wear an accelerometer (Geneactiv) on their non-dominant wrist for
8 consecutive days, 24 hrs per day, and completed a monitoring log of bed/wake times and periods
of non-wear [6]. Valid wear time was defined as at least 16 hrs of wear time per day on at least
five days [6,32]. Raw accelerometer data were processed using GGIR (version 1.10-1) in R and
incorporated participant monitoring logs to estimate the average number of nightly awakenings as an
indicator of sleep quality, time spent in inactivity as an indicator of sedentary behaviour, light (50–100
milligravitational units (mg)) and moderate-to-vigorous intensity physical activity (>100 mg) [32–36].
The psychometric properties of the instruments used to assess secondary outcomes are detailed
elsewhere [6]. Secondary outcomes included weekly minutes of moderate- and vigorous-intensity
physical activity (as measured by the Active Australia Survey) [37–39], weekly frequency of resistance
training [6,21,22], daily sitting time (Workforce Sitting Questionnaire) [40], daily energy intake and
dietary quality (Australian Eating Survey) [26,27], sleep quality (Pittsburgh Sleep Quality Index
(PSQI) [41], insomnia symptom severity (Insomnia Severity Index (ISI)) [42], sleep timing (Sleep Timing
Questionnaire) [43,44]. Participant satisfaction with and usability of the Balanced app was assessed
using the System Usability Scale [45]. The Balanced app database tracked any self-monitoring entries
made by participants and was used to determine the time to non-usage attrition (defined as the first
occurrence of a 14 consecutive day period of no self-monitoring) [21,22]. Online surveys were used to
collect participant characteristics (i.e., age, sex, marital status, ethnicity, medical history, postal code,
years of education, occupational level, hours of work (daytime, night time, afternoon), number of days
worked in previous week, average hours of work each day, diurnal preference) [46,47].
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This trial was powered to detect a between-group difference (Pooled Intervention groups vs.
Control) in the primary outcome of body weight at the primary endpoint of 6 months post-randomisation.
Assuming a mean between-group difference in body weight of 3.6 kg, standard deviation of 13.4 kg,
and a pre-post within-person correlation of 0.9, 31 participants per group were required to provide
80% power at 0.05 significance [6]. A total 38 participants per group were recruited to allow for an
anticipated ~17% attrition (total n = 116) [21].
2.2. Statistical Analyses
Analyses followed an intention-to-treat principle using all available data. Characteristics of
completers and non-completers (i.e., non-completion of the 6-month assessment) were compared
using t-tests and chi-squared tests. The proportions of participants reporting an acceptable system
usability score (≥70) [45], mean system usability scores and self-monitoring entries were compared
between intervention groups using chi-squared tests and t-test. Two series of analyses were conducted
to compare between-group differences in primary and secondary outcomes. The first compared the
Pooled Intervention groups (Enhanced and Traditional groups) and the Control group on primary and
secondary outcomes. The second set of analyses compared the Enhanced and Traditional groups on
primary and secondary outcomes. Between-group differences in primary and secondary outcomes
at 6 and 12 months were examined using Generalized Linear Mixed Models (GLMM) using an
ANCOVA (baseline-adjusted) approach. The GLMMs included fixed effects for the baseline value
of the outcome, group, time, the group × time interaction, the BMI stratification variable, a random
intercept to account for repeated measures of participants and accounted for participant clustering
in households. The distribution of response data and residual diagnostics informed the selection of
family and link functions. The magnitude of the differences between groups using observed values
at 6 and 12 months calculated was also expressed as Cohen’s d (95% CI). Between-group differences
in the time to non-usage attrition were made using Cox proportion hazards regression and plotted
using Kaplan–Meier survival estimates. Multiple imputation was performed for sensitivity analyses,
with ten datasets being imputed, including variables predicting missingness or the outcome. Data
were imputed using Chained Equations and Predicted Mean Matching. Analyses were conducted
using Stata MP (15.1) in October 2019. An alpha level of 0.05 was used for the primary outcome and all
secondary outcomes.
3. Results
Of the 116 participants who completed baseline assessments, 80 (69.8%) completed the 6-month
assessment and 54 (46.6%) completed the 12-month assessment (Figure 1). The completion rates did
not differ between groups (p = 0.193). The reasons for formal withdrawal from the trial are detailed in
Figure 1. The overall dropout rate (defined as formal withdrawal from the trial) was 16.4% (n = 19)
and was similar across groups. Completers and non-completers were similar for sociodemographic,
weight, and behavioural characteristics, except completers reported fewer symptoms of depression and
stress (Supplementary Table S2). A total of 6 household dyads (Control: 1; Traditional: 2; Enhanced: 3)
and one triad were included (Traditional: 1). Participant baseline characteristics by study group, are
shown in Table 1. The mean participant age was 44.5 years (range 19.8–64.5), 70% were female and
approximately half were employed fulltime. The mean weight was 90.7 kg and 70% were classified
as obese.
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Table 1. Baseline sociodemographic, health and behavioural characteristics of participants by group.
Pooled
Intervention Enhanced Traditional Control Total
N = 80 N = 39 N = 41 N = 36 N = 116
M (SD), N (%) M (SD), N (%) M (SD), N (%) M (SD), N (%) M (SD), N (%)
Age (years) 46.3 (9.8) 47.2 (9.4) 45.4 (10.2) 40.5 (10.7) 44.5 (10.4)
Sex
Female 57 (71.3%) 27 (69.2%) 30 (73.2%) 25 (69.4%) 82 (70.7%)
Male 23 (28.7%) 12 (30.8%) 11 (26.8%) 11 (30.6%) 34 (29.3%)
Years Education 17.1 (2.9) 17.3 (3.0) 16.9 (2.7) 14.8 (2.7) 16.4 (3.0)
Marital Status
Married/Defacto 63 (78.8%) 30 (76.9%) 33 (80.5%) 29 (80.6%) 92 (79.3%)
Not Married 17 (21.3%) 9 (23.1%) 8 (19.5%) 7 (19.4%) 24 (20.7%)
Employment
Full time 43 (53.8%) 21 (53.8%) 22 (53.7%) 19 (52.8%) 62 (53.4%)
Part time/casual 26 (32.5%) 11 (28.2%) 15 (36.6%) 13 (36.1%) 39 (33.6%)
Retired 6 (7.5%) 3 (7.7%) 3 (7.3%) 0 (0.0%) 6 (5.2%)
Other 5 (6.3%) 4 (10.3%) 1 (2.4%) 4 (11.1%) 9 (7.8%)
Weight (kg) 89.8 (13.4) 90.8 (13.1) 88.9 (13.8) 92.5 (16.1) 90.7 (14.3)
Measured BMI 31.7 (3.9) 31.9 (4.0) 31.4 (3.8) 31.9 (3.9) 31.7 (3.9)
Measured BMI Categories
BMI 25.0–29.9 25 (31.3%) 11 (28.2%) 14 (34.1%) 10 (27.8%) 35 (30.2%)
BMI 30.0–40.0 55 (68.8%) 28 (71.8%) 27 (65.9%) 26 (72.2%) 81 (69.8%)
Waist Circ. (cm) 99.6 (10.8) 99.5 (12.5) 99.6 (9.0) 99.7 (11.7) 99.6 (11.0)
HbA1c 5.5 (0.6) 5.5 (0.4) 5.5 (0.7) 5.3 (0.3) 5.4 (0.5)
Self-reported MVPA (mins.wk) 346.4 (316.3) 341.5 (270.6) 351.0 (357.7) 238.1 (239.2) 312.8 (297.8)
Resistance Training Freq. (d.wk)
0–1 Session 63 (78.8%) 32 (82.1%) 31 (75.6%) 28 (77.8%) 91 (78.4%)
2+ Session 17 (21.3%) 7 (17.9%) 10 (24.4%) 8 (22.2%) 25 (21.6%)
MVPA (mins.d) ‡ 56.4 (33.3) 56.6 (34.0) 56.3 (33.0) 49.2 (24.2) 54.4 (31.1)
Light Intensity Activity (mins.d) ‡ 197.8 (76.4) 199.8 (74.3) 196.1 (79.1) 188.0 (66.0) 195.1 (73.5)
Daily Sitting Time (mins.d) 703.0 (205.5) 667.4 (194.5) 736.8 (212.2) 678.1 (183.6) 695.3 (198.5)
Sedentary Time (mins.d) ‡ 617.7 (121.7) 606.0 (143.5) 629.7 (94.8) 584.0 (180.7) 607.4 (142.3)
Energy Intake (kj.d) 9921.6 (3274.0) 9422.1 (3518.6) 10,396.9 (2989.0) 9152.6 (2810.3) 9683.0 (3145.6)
Total diet quality (ARFS 0–73) 36.3 (8.4) 36.5 (9.0) 36.0 (8.0) 33.3 (10.0) 35.4 (9.0)
PSQI Global Score 7.1 (3.0) 7.3 (2.8) 7.0 (3.1) 6.7 (3.0) 7.0 (3.0)
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Table 1. Cont.
Pooled
Intervention Enhanced Traditional Control Total
N = 80 N = 39 N = 41 N = 36 N = 116
M (SD), N (%) M (SD), N (%) M (SD), N (%) M (SD), N (%) M (SD), N (%)
PSQI Sleep Quality Classification
Good Quality Sleep 18 (22.5%) 7 (17.9%) 11 (26.8%) 8 (22.2%) 26 (22.4%)
Poor Quality Sleep 62 (77.5%) 32 (82.1%) 30 (73.2%) 28 (77.8%) 90 (77.6%)
Insomnia Severity Index 9.2 (4.9) 9.9 (4.6) 8.5 (5.2) 7.6 (4.8) 8.7 (4.9)
PSQI Sleep Duration (hrs.d) 6.8 (1.0) 6.7 (1.1) 6.8 (1.0) 6.8 (0.9) 6.8 (1.0)
Sleep Duration (hrs.d) ‡ 6.4 (0.9) 6.4 (0.9) 6.4 (0.9) 6.7 (0.7) 6.5 (0.9)
Bed time Variability 3.4 (1.7) 3.5 (1.8) 3.2 (1.6) 3.0 (1.4) 3.3 (1.6)
Wake time Variability 2.4 (1.3) 2.3 (1.3) 2.6 (1.4) 2.4 (1.3) 2.4 (1.3)
Nightly Awakenings ‡ 2.6 (1.6) 2.8 (1.8) 2.3 (1.3) 1.6 (1.4) 2.3 (1.6)
DASS-Depression 6.2 (6.3) 5.8 (4.9) 6.5 (7.4) 8.4 (7.9) 6.9 (6.9)
DASS-Anxiety 4.5 (4.9) 4.2 (4.5) 4.7 (5.2) 5.1 (5.8) 4.7 (5.2)
DASS-Stress 10.8 (6.4) 10.8 (6.1) 10.8 (6.8) 10.9 (6.8) 10.8 (6.5)
Notes. ‡Measured using accelerometer.
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3.1. Weight and Behavioural Outcomes
At 6 months, weight was not significantly different between the Pooled Intervention groups
and Control group (difference = −0.92, 95% CI (−3.33, 1.48)) or 12 months (difference = 0.00, 95% CI
(−2.62, 2.62)) (Table 2). Individual weight change and the group mean weight change from baseline to
6 months and 12 months is shown in Figure 2a–d and Supplementary Figure S1a–d, respectively. Daily
energy intake was significantly lower in the Pooled Intervention group than the Control group at 6
months (difference = −1037.03, 95% CI (−2028.84, −45.22)) but not at 12 months (difference = −913.36,
95% CI (−2030.75, 204.04)) (Table 2). Severity of insomnia symptoms was significantly lower in the
Pooled Intervention group than the Control group at 12 months (difference = −2.59, 95% CI (−4.79,
−0.39)) (Table 2). The Pooled Intervention group was significantly more likely to report meeting
resistance training guidelines than the Control group at 6 months (OR = 7.83, 95% CI (1.08, 56.63),
p = 0.041), but not at 12 months (OR = 5.68, 95% CI (0.55, 58.83), p = 0.145) (Figure 3). There were no
other significant differences between the Pooled Intervention group and the Control group at either 6
or 12 months (Table 2).
Table 2. Baseline adjusted group differences between Pooled and Control groups at 6 months and
12 months.
Outcome Control Pooled Intervention Group Difference (95% CI)
M (95% CI) M (95% CI)
Weight (kg)
6 Months 87.67 (85.58, 89.75) 86.75 (85.45, 88.04) −0.92 (−3.33, 1.48)
12 Months 87.21 (85.00, 89.43) 87.21 (85.74, 88.69) −0.00 (−2.62, 2.62)
Waist Circ. (cm) ‡,†
6 Months 97.14 (94.91, 99.37) 96.52 (95.14, 97.90) −0.62 (−3.18, 1.95)
12 Months 95.45 (93.10, 97.80) 96.04 (94.49, 97.59) 0.59 (−2.17, 3.36)
HbA1c
6 Months 5.44 (5.31, 5.57) 5.45 (5.37, 5.53) 0.01 (−0.15, 0.16)
12 Months 5.32 (5.17, 5.46) 5.28 (5.18, 5.37) −0.04 (−0.21, 0.13)
Self-report MVPA (mins.wk) †
6 Months 415.19 (294.31, 536.06) 469.48 (374.56, 564.40) 54.29 (−86.96, 195.54)
12 Months 415.53 (182.85, 648.21) 442.30 (329.19, 555.40) 26.77 (−225.90, 279.43)
MVPA (mins.d) ‡,†
6 Months 67.35 (55.01, 79.70) 69.98 (61.54, 78.42) 2.63 (−12.22,17.48)
12 Months 66.76 (56.37, 77.15) 73.54 (61.56, 85.53) 6.78 (−9.19,22.76)
Light Intensity Activity (mins.d) ‡,†
6 Months 224.57 (200.90, 248.24) 224.03 (206.60, 241.45) −0.54 (−29.45, 28.37)
12 Months 219.20 (197.49, 240.92) 222.49 (197.50, 247.47) 3.28 (−30.64, 37.20)
Daily Sitting Time (mins.d)
6 Months 682.86 (601.06, 764.66) 652.30 (602.49, 702.11) −30.56 (−123.65, 62.53)
12 Months 568.56 (483.50, 653.61) 568.66 (518.92, 618.40) 0.10 (−100.25, 100.46)
Sedentary Time (mins.d) ‡,†
6 Months 633.66 (592.52, 674.80) 661.33 (627.06, 695.60) 27.67 (−30.40, 85.74)
12 Months 649.40 (597.45, 701.35) 617.38 (576.14, 658.62) −32.02 (−99.47, 35.43)
Energy Intake (kj.d)
6 Months 9117.77 (8256.43, 9979.11) 8080.74 (7557.45, 8604.03) −1037.03 (−2028.84, −45.22)
12 Months 9105.88 (8169.46, 10042.29) 8192.52 (7567.82, 8817.21) −913.36 (−2030.75, 204.04)
PSQI Global Score †
6 Months 6.76 (5.50, 8.02) 5.96 (5.24, 6.68) −0.80 (−2.26, 0.67)
12 Months 5.96 (4.66, 7.26) 5.30 (4.35, 6.25) −0.66 (−2.27, 0.95)
Insomnia Severity Index
6 Months 8.03 (6.33, 9.74) 6.43 (5.41, 7.46) −1.60 (−3.56, 0.36)
12 Months 8.16 (6.31, 10.00) 5.56 (4.33, 6.80) −2.59 (−4.79, −0.39)
Bed time Variability †
6 Months 2.78 (2.18, 3.39) 3.16 (2.76, 3.56) 0.38 (−0.35, 1.11)
12 Months 3.36 (2.65, 4.06) 3.02 (2.57, 3.46) −0.34 (−1.18, 0.50)
Int. J. Environ. Res. Public Health 2020, 17, 6200 10 of 21
Table 2. Cont.
Outcome Control Pooled Intervention Group Difference (95% CI)
M (95% CI) M (95% CI)
Wake time Variability ¥
6 Months 2.03 (1.56, 2.50) 2.44 (2.13, 2.75) 0.18 (−0.08, 0.44)
12 Months 2.49 (1.93, 3.04) 2.16 (1.82, 2.51) −0.14 (−0.41, 0.13)
Nightly Awakenings ‡
6 Months 2.28 (1.74, 2.83) 2.18 (1.85, 2.51) −0.10 (−0.74, 0.53)
12 Months 1.97 (1.27, 2.67) 2.10 (1.65, 2.56) 0.13 (−0.71, 0.98)
DASS-Depression †
6 Months 6.44 (4.88, 8.01) 4.96 (3.70, 6.23) −1.48 (−3.54, 0.58)
12 Months 3.12 (1.32, 4.91) 4.84 (3.48, 6.20) 1.72 (−0.61, 4.05)
DASS-Anxiety
6 Months 3.41 (2.10, 4.72) 3.19 (2.40, 3.99) −0.21 (−1.71, 1.29)
12 Months 3.13 (1.75, 4.51) 2.68 (1.79, 3.58) −0.44 (−2.07, 1.18)
DASS-Stress
6 Months 9.96 (7.76, 12.17) 8.93 (7.60, 10.26) −1.03 (−3.56, 1.50)
12 Months 9.34 (6.95, 11.73) 8.20 (6.61, 9.79) −1.14 (−3.98, 1.71)
Notes: ‡Measured using accelerometer. †Model included robust estimator. ¥ Modelled using Generalized Linear
Mixed Model (Gaussian Log link). Group difference is the difference between groups (adjusted for baseline value of
outcome) at each assessment.
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Figure 2. Individual weight change from baseline to 6 months by study group. (a) Control group participant 
change at 6 months; (b) Traditional group participant change at 6 months; (c) Enhanced group participant 
change at 6 months; (d) Pooled group participant change at 6 months. 
Figure 2 Notes. Only includes participants with weight measured at 6 months. Average (SD) 
weight loss at 6 months: Control (n = 21) = −1.54 (4.35); Traditional (n = 32) = −3.51 (4.77); Enhanced (n 
= 27) = −1.65 (3.77); Pooled (n = 59) = −2.66 (4.40). Red line indicates average weight loss for group. 
Figure 2. Individual weight change from baseline to 6 months by study group. (a) Control group
participant change at 6 months; (b) Traditional group participant change at 6 months; (c) Enhanced
group participant change at 6 months; (d) Pooled group participant change at 6 months.
Figure 2 Notes. Only includes participants with weight measured at 6 months. Average (SD)
weight loss at 6 months: C ntrol (n = 21) = −1.54 (4.35); Traditional (n = 32) = −3.51 (4.77); Enhanced
(n = 27) = −1.65 (3.77); Pooled (n = 59) = −2.66 (4.40). Red line indicates average weight loss for group.
Figure 3 Notes. Only includes participants with weight measured at 6 months. The Pooled
Intervention group was significantly more likely to report meeting resistance training guidelines than
the Control group at 6 months (OR = 7.83, 95% CI (1.08, 56.63), p = 0.041), but not at 12 months
(OR = 5.68, 95% CI (0.55, 58.83), p = 0.145). Data are available from observations; the proportion
reporting sufficient RT (2+ Days/week) in the Control group was 8/36 (22.2%), 3/21 (14.3%) and 2/17
(11.8%) at baseline, 6 months and 12 months; for the Pooled Intervention group this was 17/80 (21.3%),
26/60 43.3%) and 13/37 (35.1%) at baseline, 6 months and 12 months, respectively.
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Figure 3. Proportion of Control Group and Pooled participants reporting sufficient resistance training
(RT) at Baseline, 6 onths and 12 onths.
When comparing the two intervention groups, waist circumference was significantly lower in the
Traditio al group compared to the Enhanced group at 6 months (diffe nce = 2.69, 95% CI (0.20, 5.18)), but
not at 12 months (difference = 0.75, 95% CI (−2.08, 3.59)) (Table 3). Sedentary time was significantly lower
in the Traditional group than in the Enhanced group at 12 onths (difference =105.66, 95% CI (30.83,
180.48)) (Table 3). Bed tim variability was si nificantly lower (improved) in the Enhanced group at 12
months (differe ce = −1.08, 95% CI (−1.86, −0.29)) (Table 3). There were no other differences between the
two intervention groups at either 6 or 12 . Supple e tary Tables S3 and S4 present the descriptive
statistics for the rimary and seco dary outcomes and indicate that th magnitude of d ferences betwee
groups (Cohen’s d) at each ass ssment point w re of a small-to-moderate magnitude at 6 months and
were smaller at 12 months. Sens tivity analyses using multiple imputation for missing data identified a
milar pa tern of results (Suppleme tary Tables S5 a d S6).
Table 3. Baseline adjusted group ifferences between Enhanced and Traditional groups at 6 months
and 12 months.
Outcome Traditional Enhanced Group Difference (95% CI)
M (95% CI) M (95% CI)
Weight (kg)
6 Months 85.37 (83.71, 87.04) 87.28 (85.46, 89.10) 1.91 (−0.50, 4.31)
12 Months 86.34 (84.54, 88.14) 87.19 (85.06, 89.32) 0.85 (−1.89, 3.59)
Waist Circ. (cm)
6 Months 95.12 (93.41, 96.84) 97.81 (95.93, 99.69) 2.69 (0.20, 5.18)
12 Months 95.42 (93.57, 97.27) 96.17 (93.96, 98.39) 0.75 (−2.08, 3.59)
HbA1c
6 Months 5.46 (5.35, 5.57) 5.45 (5.33, 5.57) −0.01 (−0.17, 0.15)
12 Months 5.36 (5.23, 5.48) 5.18 (5.02, 5.33) −0.18 (−0.38, 0.02)
Self-report MVPA (mins.wk) †
6 Mont s 555.61 (433.42, 677.79) 404.16 (260.54, 547.78) −151.45 (−330.31, 27.41)
12 Months 532.45 (380.27, 684.63) 365.56 (219.20, 511.91) −166.90 (−374.08, 40.29)
MVPA (mins.d) ‡,†
6 Months 76.28 (60.97, 91.58) 61.54 (50.82, 72.26) −14.74 (−37.03, 7.56)
12 Months 76.66 (58.12, 95.19) 70.43 (51.69, 89.18) −6.22 (−35.66, 23.22)
Light Intensity Activity (mins.d) ‡,†
6 Months 224.97 (197.83, 252.10) 209.09 (184.21, 233.96) −15.88 (−56.55, 24.79)
12 Months 222.45 (184.93, 259.97) 208.14 (175.34, 240.95) −14.31 (−68.62, 40.00)
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Table 3. Cont.
Outcome Traditional Enhanced Group Difference (95% CI)
M (95% CI) M (95% CI)
Daily Sitting Time (mins.d)
6 Months 677.99 (615.46, 740.53) 652.09 (583.53, 720.65) −25.90 (−116.44, 64.64)
12 Months 549.21 (487.68, 610.74) 618.45 (530.56, 706.35) 69.24 (−39.00, 177.48)
Sedentary Time (mins.d) ‡,†
6 Months 648.89 (612.76, 685.01) 688.27 (635.49, 741.06) 39.38 (−21.99, 100.76)
12 Months 594.00 (549.77, 638.24) 699.66 (635.44, 763.87) 105.66 (30.83, 180.48)
Energy Intake (kj.d)
6 Months 8189.80 (7487.54, 8892.07) 8305.46 (7520.13, 9090.79) 115.65 (−939.39, 1170.70)
12 Months 8603.07 (7798.02, 9408.12) 7878.94 (6838.57, 8919.31) −724.13 (−2053.96, 605.70)
PSQI Global Score †
6 Months 6.14 (5.22, 7.06) 5.78 (4.62, 6.94) −0.36 (−1.86, 1.14)
12 Months 5.34 (4.00, 6.67) 5.31 (4.13, 6.49) −0.03 (−1.79, 1.74)
Insomnia Severity Index
6 Months 6.27 (4.89, 7.66) 6.89 (5.33, 8.45) 0.62 (−1.44, 2.67)
12 Months 5.86 (4.31, 7.40) 5.19 (3.26, 7.13) −0.66 (−3.12, 1.80)
Bed Time Variability
6 Months 3.43 (2.79, 4.06) 2.83 (2.41, 3.25) −0.60 (−1.37, 0.18)
12 Months 3.45 (2.80, 4.11) 2.38 (1.97, 2.78) −1.08 (−1.86,−0.29)
Wake time Variability ¥
6 Months 2.49 (2.07, 2.91) 2.39 (1.92, 2.85) −0.04 (−0.29, 0.21)
12 Months 2.22 (1.80, 2.64) 2.09 (1.54, 2.64) −0.06 (−0.38, 0.26)
Nightly Awakenings ‡
6 Months 2.36 (1.91, 2.81) 2.38 (1.89, 2.86) 0.02 (−0.63, 0.67)
12 Months 2.48 (1.92, 3.04) 1.83 (1.03, 2.63) −0.65 (−1.62, 0.32)
DASS-Depression †
6 Months 4.61 (3.30, 5.92) 5.02 (2.74, 7.30) 0.41 (−2.25, 3.07)
12 Months 5.18 (3.47, 6.89) 3.82 (1.87, 5.77) −1.36 (−4.04, 1.32)
DASS-Anxiety
6 Months 3.35 (2.32, 4.39) 3.27 (2.11, 4.43) −0.08 (−1.60, 1.43)
12 Months 3.40 (2.28, 4.52) 1.86 (0.49, 3.24) −1.54 (−3.29, 0.21)
DASS-Stress
6 Months 10.04 (8.29, 11.78) 8.02 (6.08, 9.96) −2.02 (−4.58, 0.54)
12 Months 9.31 (7.30, 11.32) 7.10 (4.51, 9.70) −2.21 (−5.48, 1.05)
Notes: ‡Measured using accelerometer. †Model included robust estimator. ¥ Modelled using Generalized Linear
Mixed Model (Gaussian Log link). Group difference is the difference between groups (adjusted for baseline value of
outcome) at each assessment.
3.2. Usage Outcomes
Over the 12-month study period, the mean total number of self-monitoring entries did not
differ between the two intervention groups (Traditional = 156.5 (±102.8); Enhanced = 140.4 (±83.3),
p = 0.440) (Table 4). The average number of self-monitoring entries was lower for participant-entered
metrics (e.g., Food, Body Weight) than for the metrics automatically entered by the Fitbit (e.g., Fitbit
MVPA) (Table 4). The proportion of intervention group participants who self-monitored weight
gradually declined during the intervention (Figure 4). Over the 12-month period, a total of 62 (77.5%)
participants succumbed to non-usage attrition (Traditional = 29 (70.7%); Enhanced = 33 (84.6%)), and
there was no statistically significant difference between intervention groups (HR = 1.26, 95% CI 0.77,
2.08, p = 0.360) (Figure 5). The overall mean system usability score (SUS) was 71.5 (±17.3), and did
not significantly differ between the Traditional (74.0 (±14.2)) and Enhanced groups (68.5 (±20.6)),
p = 0.109). The proportion of responses to the individual SUS items by intervention group is shown in
Supplementary Table S7.
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Table 4. Number of self-monitoring entries made by Move, Eat, Sleep participants using the Balanced app over 12 months.
Outcome Traditional Enhanced Total
N Mean SD Min Max N Mean SD Min Max N Mean SD Min Max p-Value




41 152.5 102.1 0 340 39 122.5 77.9 0 344 80 137.9 91.8 0 344 0.140
Food Entries 41 126.9 101.8 0 337 39 83.2 68.4 0 313 80 105.6 89.3 0 337 0.030
Sleep Entries N/A N/A N/A N/A N/A 39 119.7 83.7 0 352 39 119.7 83.7 0 352 N/A
Body Weight






Entries 41 151.0 100.9 0 339 39 121.5 78.0 0 344 80 136.6 91.1 0 344 0.150
Daily Steps




41 127.2 96.5 0 331 39 68.5 62.4 0 274 80 98.6 86.4 0 331 <0.001
Notes: † Total entries is the number of self-monitoring entries for physical activity, diet, or weight in the Traditional group, and the number of self-monitoring entries for physical activity,
diet, sleep or weight in the Enhanced group. ‡ Physical activity entries include Fitbit MVPA, Daily Steps, and Resistance Training entries.
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4. Discussion
The primary aim of the current study was to compare the effect of the Pooled Intervention
compared to the Control group on the primary outcome of body weight. Body weight did not
significantly differ between the Pooled Intervention group compared to the Control at 6 or 12 months,
indicating weight loss did not differ between the groups. The Pooled Intervention group reduced
energy intake, insomnia symptom severity, and increased resistance training in comparison to the
Control group. While body weight did not significantly differ between the two interventions groups,
the Traditional group improved waist circumference and sedentary time in comparison to the Enhanced
group, and the Enhanced group improved (reduced) the variability in bed time in comparison the
Traditional group.
Findings from meta-analyses have shown that e- and m-health weight loss interventions are
effective in comparison to control groups [3,20]. However, in the current study, body weight did not
significantly differ between any of the study groups and this may be due to several potential reasons.
Importantly, all groups lost weight relative to baseline including the Control group (Figure 2a–d).
Although weight loss among control group participants is commonly reported in behavioural weight
loss interventions [48], the magnitude of weight loss in the Control group (−1.54 kg at 6 months) in the
current study was not anticipated. Potential explanations for this include participants volunteering
to participate in a weight loss trial, being allocated to the wait list Control group and engaging
in alternative weight loss strategies despite their group allocation. Although no information is
available concerning if Control group participants did participate in other weight loss interventions,
all participants were asked to not participate in other weight loss interventions during the study.
The physical activity intervention used in this study has been shown to increase resistance training
in previous studies [21,22], this is consistent with the greater frequency of resistance training in
the Pooled Intervention relative to the Control group observed in the current study. Participation
in resistance training has important health benefits [4,49]. However, it is unclear how the greater
frequency of resistance training in the Pooled Intervention influenced the lean muscle mass, body
composition and corresponding body weight of these participants and offset any differences in weight
loss relative to the Control group. Examining body composition and related outcomes would help to
clarify this issue in future studies. Additionally, inclusion criteria did not consider participant lifestyle
behaviours, and participants had relatively high levels of moderate-to-vigorous intensity physical
activity, and sub-clinical levels of insomnia at baseline [42]. Consequently, despite modest reductions
in energy intake at 6 months, participants may have had limited ability to further improve target
behaviours and achieve weight loss over the study period.
With the exception of reduced (i.e., improved) bed time variability in the Enhanced group, no other
sleep outcome differed between the two intervention groups. Though insomnia treatments typically
focus on reducing wake time variability to help improve sleep drive [50], reduced bed time variability
is part of sleep hygiene recommendations (e.g., have a regular sleep pattern), and is associated with
less frequent insufficient sleep [44]. The reduced bed time variability may reflect changes in participant
behaviours to improve sleep in the current study. In trials that included participants with poorer sleep
quality and more severe insomnia symptoms than in the current trial, the sleep interventions improved
various indicators of sleep health at three and 6 months [21,22]. As cognitive and/or behavioural
interventions for sleep produce larger improvements when participants have poorer sleep quality at
baseline [51], participants in the current study may have had limited the potential for improvement in
sleep quality. Additionally, both intervention groups received the same physical activity intervention
and were more likely to meet resistance training guidelines at 6 months than the Control group.
As resistance training has been shown to improve sleep quality [52] this may have attenuated the
additional effect of the sleep intervention in the Enhanced group [22].
Although the mechanisms are not well established [7], poor sleep may contribute to weight
gain by increased energy intake [12,17] and reduced physical activity levels [11,53]. Consequently,
it was hypothesised that the Enhanced group which included the sleep intervention would produce
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greater weight loss and improvements in activity and diet behaviours than the Traditional group; this
did not occur. Most studies that have examined how sleep influences diet are short term (<5 days)
laboratory-based experiments that restrict the sleep duration (<5.5 hrs/d) of people with recommended
sleep durations (i.e., 7–9 hrs/d) [12,13,54]. In addition, the previously mentioned study that reported
greater weight loss when physical activity, diet and sleep were targeted, compared to physical activity
and diet, only examined weight loss over 12 weeks [5]. By comparison, the current study included
participants with mostly sub-clinical levels of insomnia and average sleep durations of 6.5 hrs/d, and
aimed to improve sleep over six months in the community setting in the context of a weight loss
intervention. These differences may partly explain why the two intervention groups did not differ
on weight and energy intake. Moreover, as the dose–response relationship between improved sleep
(i.e., dimension of sleep health, magnitude and duration of change) and daily energy intake is unclear,
it is possible that the modest improvements in sleep quality and insomnia symptoms over the study
period were not sufficient to have any influence on total energy intake.
Self-monitoring behaviours and weight are important determinants of behaviour change and
weight loss, respectively [3,55]. While there is no consensus on the amount of use and engagement
needed to change behaviours, consistent with the current study, most m-health and e-health
interventions report that usage declines over time [21,22,55–57]. The proportion of participants
who succumbed to non-usage attrition in the current study (Traditional = 70.7%; Enhanced 84.6%)
did not differ between intervention groups and is broadly comparable to other interventions using
the Balanced app to target physical activity and sleep combination (68–89%) [21,22]. However, direct
comparisons between studies are difficult due to differences in self-monitoring methods as the current
study used a combination of Fitbit and manual entry, and the previous studies only used manual
entry [21,22]. As the Enhanced group had a significantly lower number of self-monitoring entries that
were manually entered by participants (i.e., steps, resistance training, food, and weight) (Table 4), it is
possible that the self-monitoring requirements in the Enhanced group were too burdensome. This
issue combined with the number of different intervention components and delivery modalities used in
the intervention (see Table S1) may have overwhelmed some participants limiting their behavioural
changes and subsequent weight loss [58]. Although efficacy of simultaneous and sequentially delivered
interventions does not appear to differ [58] the self-monitoring differences between groups highlights
the importance of carefully targeting and operationalising intervention components in simultaneous
multiple behaviour interventions [59,60].
The current study has several strengths. These include the randomised design, the length of the
intervention and follow-up relative to many weight loss interventions, and targeting improved sleep
health as part of a weight loss intervention [3,54]. Limitations, however, include the potential presence
of undiagnosed sleep conditions (although the baseline scores on the PSQI and insomnia severity index
indicate participants did not have severely impaired sleep). Further, the wrist worn accelerometer is
less useful than thigh worn devices for assessing sedentary behaviour, due to the postural component
needed to accurately define sedentary behaviour [61].
In conclusion, relative to the Control group, the Pooled Intervention group did not differ in
terms of body weight, but improved resistance training, and reduced energy intake and insomnia
symptom severity. Additional improvements in weight loss, physical activity, diet and sleep behaviours
associated with targeting improvements in physical activity, diet and sleep in combination compared
to physical activity and diet were not evident. Participants had relatively favourable behavioural
profiles at baseline which may have limited the ability of participants to further improve behaviours,
and all groups lost weight relative to baseline potentially limiting the ability to detect between-group
differences in weight loss.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/17/17/6200/s1.
Figure S1: Individual weight change from baseline to 12 months by study group, Table S1: Overview of the
intervention components and delivery methods in the Move, Eat & Sleep Study, Table S2: Comparison of
completers and non-completers in Move, Eat & Sleep Study, Table S3: Weight, cardiovascular risk factors, lifestyle
behaviours, and mental health characteristics at baseline, 6 month and 12 month health by Control & Pooled
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Intervention Groups, Table S4: Weight, cardiovascular risk factors, lifestyle behaviours, and mental health
characteristics at baseline, 6 month and 12 month health Traditional & Enhanced Groups, Table S5: Sensitivity
analyses using multiply imputed data (10 imputations); Baseline adjusted group differences between Pooled
and Control Groups at 6 months and 12 months, Table S6: Sensitivity analyses using multiply imputed data (10
imputations). Baseline adjusted group differences between Enhanced and Traditional Groups at 6 months and 12
months, Table S7: System Usability Scores for Move, Eat & Sleep participants using the Balanced App at 6 months.
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